
Individualized, evidence-based care in a private Hollywood Hills setting. Same clinical team from intake through aftercare.

Depression and substance use disorders are among the most commonly co-occurring conditions in clinical practice. Each condition tends to worsen the other — substances are frequently used to manage depression symptoms, while sustained substance use worsens the underlying condition and makes recovery harder. Depression also frequently co-occurs alongside anxiety disorders and PTSD, which can compound the severity of mood symptoms and significantly raise the risk of relapse.
Treating only the addiction without addressing depression leaves the most powerful driver of substance use unaddressed. This is why integrated dual diagnosis treatment — treating both conditions simultaneously within a unified clinical plan — produces significantly better outcomes than treating either in isolation.
Depression presents alongside addiction in ways that can make diagnosis and treatment more complex. Substance use can mimic, mask, or worsen depression symptoms. A comprehensive clinical assessment — conducted after a sufficient period of stabilization — is essential for accurate diagnosis and appropriate treatment planning.
Depression frequently worsens during and after withdrawal. Distinguishing substance-induced depression from primary depressive disorder requires a period of sobriety and careful assessment.
Our admissions team is available around the clock — confidentially, and without pressure.
Comprehensive assessment of mood history, substance use patterns, and medication response to distinguish primary from substance-induced depression.
Antidepressant selection coordinated with addiction recovery — avoiding medications with abuse potential while targeting mood stabilization.
Structured therapy that rebuilds rewarding activities and social connection, countering the withdrawal and isolation that fuel both conditions.
"When we treat the depression alongside the addiction, we address the root cause — not just the symptom. That's when real recovery begins."

A thorough assessment of mood history, substance use patterns, and medication response allows us to distinguish primary from substance-induced depression. Antidepressant selection is coordinated with recovery goals — avoiding medications with abuse potential while targeting mood stabilization.

CBT and behavioral activation rebuild rewarding activities and social connection — countering the withdrawal and isolation that fuel both depression and substance use. Individual and group sessions run in parallel throughout treatment.

Treating only the addiction without addressing depression leaves the most powerful driver of relapse unresolved. Our unified clinical plan targets both conditions simultaneously — because lasting recovery depends on it.

Recovery extends beyond discharge. Our step-down PHP/IOP programming and alumni community keep clients connected, accountable, and supported during the months and years that follow residential treatment.

You don't have to face depression and addiction alone. Our team of compassionate clinicians is available around the clock — confidentially, and without pressure — to guide you toward lasting recovery.
Substance-induced depression typically improves significantly within 4–8 weeks of sobriety. If depression was present before substance use, it likely requires its own treatment.
Often yes, and coordination matters. Psychiatric medications for depression need to be selected with awareness of addiction history and potential interaction effects.
Yes. We're in-network with HealthSmart, MultiPlan, PMCS, and TriWest, and most major commercial PPO plans — Blue Cross Blue Shield, Aetna, United Healthcare, Anthem, Cigna, Optum, and others — cover integrated dual-diagnosis treatment for depression and co-occurring substance use disorder under the Mental Health Parity and Addiction Equity Act. Coverage depends on your specific plan and level of care. Our admissions team verifies your benefits in detail before you commit to anything.
Most clients begin with a medically supervised detox (5 to 10 days), followed by residential treatment of an individualized length. PHP and IOP step-down programming typically add another 4 to 12 weeks. For depression, the clinical picture may require additional time to stabilize mood — our team adjusts the continuum based on how each client is progressing rather than defaulting to a fixed timeline.
Treatment begins with a comprehensive psychiatric assessment covering mental health history, substance use, and current symptoms. Our clinical team builds a unified treatment plan that addresses depression and addiction simultaneously — not sequentially. Evidence-based therapies (CBT, DBT, and when appropriate, EMDR for trauma-related depression) are integrated with psychiatric medication management and holistic modalities. Before discharge, we build a structured aftercare plan.
For clients with significant depression alongside active substance use, residential treatment offers the most stable environment for early recovery — 24/7 clinical support, immersive therapeutic programming, and removal from environmental stressors and triggers. PHP and IOP are appropriate as step-down care once the client is stabilized and progressing. Our admissions team assesses the right level of care at intake.
Our primary evidence-based therapies for depression include Cognitive Behavioral Therapy (CBT) and, where appropriate, Dialectical Behavior Therapy (DBT) for emotional regulation. EMDR is used when depression is rooted in unresolved trauma. Psychiatric medication management — with careful coordination to avoid medications that carry dependence risk — runs alongside therapy. Holistic modalities including yoga, breathwork, and mindfulness practices support mood regulation through the full course of treatment.
Co-occurring disorders reinforce each other. We treat both simultaneously — with psychiatric support, therapy, and medication management.